Headlines
Analysis-Novo's board bust-up to sharpen drugmaker's focus on US consumers
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Boardroom drama at Wegovy-maker Novo Nordisk has...
22nd October, 2025
healthcare
Latest articles
Finance
WeightWatchers partners with Amazon for easy weight-loss drug delivery
By Amina Niasse NEW YORK (Reuters) -WeightWatchers said on Monday it will partner with Amazon to del...
20th October, 2025
Finance
Novo, Lilly's shares drop as Trump vows weight-loss drug price cuts
COPENHAGEN (Reuters) -Novo Nordisk's shares fell 5.6% in early trade on Friday after U.S. President...
17th October, 2025
Headlines
China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
(Reuters) -Chinese biotech Hansoh Pharma said on Friday its units have signed a license agreement wo...
16th October, 2025
Headlines
UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug
(Reuters) -The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV H...
16th October, 2025
Headlines
Trump, Merck KGaA announce deal to cut some IVF drug prices
By Patrick Wingrove (Reuters) -U.S. President Donald Trump and Germany's Merck KGaA on Thursday said...
16th October, 2025
Headlines
Trump says price of Ozempic will be lowered
WASHINGTON (Reuters) -U.S. President Donald Trump said on Thursday that the price of Novo Nordisk's...
16th October, 2025
Finance
Roche to sell flu pill for $50 to cash-paying US patients
By Patrick Wingrove (Reuters) -Roche on Thursday launched direct-to-consumer U.S. sales of its influ...
16th October, 2025
Finance
Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares
By Marleen Kaesebier (Reuters) -German pharmaceuticals and technology company Merck KGaA slightly im...
16th October, 2025
Headlines
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
(Reuters) -Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 bi...
15th October, 2025
Finance
India's Infosys wins $1.6 billion deal from UK's National Health Service
BENGALURU (Reuters) -India's Infosys said on Tuesday it has won a 1.2 billion pound ($1.59 billion)...
14th October, 2025
Headlines
J&J to spin off orthopedics business, sees 2026 sales growth of over 5%
By Patrick Wingrove (Reuters) -Johnson & Johnson on Tuesday raised its 2025 sales forecast after rep...
14th October, 2025